LGR4减弱MGP表达并抑制EGFR激活诱导的三阴性乳腺癌转移

Qishuang Li1, Yankun Gao2, Zitian Huo3

  • 1State Key Laboratory of Targeting Oncology, National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University Nanning 530021, Guangxi, PR China.

概括

富含白的重复含有G蛋白结合受体4 (LGR4) 通过调节动因细胞骨来促进三阴性乳腺癌 (TNBC) 转移. 这项研究揭示了LGR4抑制MGP表达,减少EGFR激活诱导的TNBC传播.